The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer

Thyroid

Volumn 16, Issue 10, 2006, Pages 1019-1023

  Kulkarni, K ^a   Van Nostrand, Douglas ^a   Atkins, F ^a   Aiken, M ^a   Burman, K ^a   Wartofsky, L ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; DOSIMETRY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; THYROID CANCER;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; IODINE RADIOISOTOPES; LEUKOCYTE COUNT; LYMPHATIC METASTASIS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; THYROID NEOPLASMS;

EID: 33846460854     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.1019     Document Type: Article

References (19)

1. Van Nostrand D 2006 Radioiodine treatment for distant metastases. In: Wartofsky L, Van Nostrand D (eds) Thyroid Cancer: A Comprehensive Guide to Clinical Management. Humana Press, Totowa, pp. 411-425.
2. Benua RS, Cicale NR, Sonenberg M, Rawson RW 1962 The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. AJR 87:171-182.
3. Leeper RD, and Shimaoka K 1980 Treatment of metastatic thyroid cancer. Clin Endocrinol Metab 9:383.
4. Van Nostrand D, Atkins F, Yeganeh F, Acio, E, Bursaw R, Wartofsky L 2002 Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma. Thyroid 12:121-134.
5. Beierwaltes WH 1978 The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med 8:79-94.
6. Schlumberger M, Challeton C, De Vathaire F 1996 Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37:598-605.
7. Hindié E, Melliere D, Lange F, Hallaj L, Labriolle-Vaylet C, Jeanguillaume C, Lange J, Perlemuter L, Askienazy S 2003 Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis? Eur J Nuc Med 30:974-981.
8. Brown AP, Greening WP, McCready VR, Shaw HJ, Harmer CL 1984 Radioiodine treatment of metastatic thyroid carcinoma: The Royal Marsden Hospital experience. Br J Radiol 57:323-327
9. Petrich T, Widjaja A. Musholt TJ, Hofmann M, Brunkhorst T, Ehrenheim C, Oetting G, Knapp WH 2001 Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: Side effects and influence of age. Eur J Nucl Med 28:203-208.
10. Menzel C, Grunwald F, Schomburg A, Palmedo H, Bender H, Spath G, Biersack HJ 1996 "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma. J Nucl Med 37:1496-1503.
11. Guralnik DB (ed) Webster's New World Dictionary of the American Language, Second College Edition. Simon and Schuster, New York, 1980.
12. Leeper RR 1985 Thyroid cancer. Med Clin North Am 69:1079-1096.
13. Turtle RM, Pentlow K, Qualey R, Larson S, Robbins RJ 2002 Empiric Radioactive iodine (RAI) dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with metastatic thyroid cancer [Abstract 177]. 74th Annual meeting, American Thyroid Association. Los Angeles CA: October 10-13, p. 198.
14. Dorn R, Kopp J, Vogt H, Heidenreich P, Carroll RG, Gulec SA 2003 Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: Largest safe dose using a risk-based approach. J Nucl Med 44:451-456.
15. Sgouros G 1993 Bone marrow dosimetry for radioimmunotherapy: Theoretical considerations. J Nucl Med 34:689-694.
16. Thomas SR, Maxon HR, Kereiakes JG, Saenger EL 1997 Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well differentiated thyroid cancer. Radiology 122:731-737.
17. Thomas SR, Samaratunga RS, Sperling M, Maxon HR 1993 Predictive estimate of blood dose from external counting data preceding radioiodine therapy for thyroid cancer. Nucl Med Biol 20:157-162.
18. 131I therapy for thyroid cancer. Radiology 137:839-842.
19. 131I. J Nucl Med 44:898-903.